Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Strategic Research Report

Scope of the Report

The global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market size is predicted to grow from US$ 682 million in 2025 to US$ 1,001 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.

Chlorhexidine Gluconate (CHG) products for patient skin antisepsis are medical-grade antiseptic product specifically formulated to disinfect and cleanse the skin, thereby reducing the presence of harmful microorganisms. These products are widely used in healthcare settings for various purposes, including preoperative skin preparation and routine patient hygiene.

Chlorhexidine gluconate (CHG) products are specially formulated for disinfection and cleaning of the skin, which can effectively reduce the presence of harmful microorganisms. They are widely used for preoperative skin preparation and routine patient hygiene. Common product types include solutions, washes, wipes, shampoo caps, brushes, applicators, etc.

Chlorhexidine gluconate has a killing effect on Gram-positive and Gram-negative bacteria, facultative anaerobes, aerobic bacteria and yeasts. It is particularly effective against Gram-positive bacteria. With the advent of an aging population, the number of surgeries worldwide has increased year by year. According to statistics, more than 300 million people undergo surgical operations worldwide each year, and surgical site infections (SSIs) and the wounds they cause are also increasing. It refers to nosocomial infections secondary to surgery that occur at or near the surgical incision, deep organs or cavities. It is one of the serious complications after modern surgery and orthopedics, a common cause of unplanned readmissions, and a global problem. SSI patients account for 2% to 5% of hospitalized surgical patients, and the annual incidence rate varies. The number of SSI patients in the United States is 160,000 to 300,000 per year. Studies have shown that chlorhexidine is more advantageous than povidone-iodine in preventing total infection and superficial site infection after potentially contaminated surgery.

With the outbreak of COVID-19, chlorhexidine gluconate ushered in explosive growth in 2020-2021. From a global perspective, Europe and the United States are the core market areas for chlorhexidine gluconate (CHG) products, especially North America, which accounts for 43% of the revenue share, followed by Europe, which accounts for 35% of the market share. The Asia-Pacific region currently mainly uses povidone-iodine for preoperative skin disinfection, but with the continuous expansion of awareness of chlorhexidine gluconate products and the gradual deepening of market promotion, there will be huge market potential in the future.

There are many global players in the chlorhexidine gluconate market, with a wide variety of product types, but most of them are small in scale. The top five manufacturers are mainly European and American companies, namely BD, Ecolab, Stryker, Molnlycke, and Xttrium, which will account for more than 60% of the global market share in 2023. Among them, BD's ChloraPrep applicator products are the world's leading sales, with annual sales exceeding 150 million units. Product types have also gradually evolved from the initial solutions and lotions to wet wipes, gloves, brushes, shampoo caps, etc. Currently, lotions and solution products occupy the core market share.

Chlorhexidine gluconate products are widely used for patient skin disinfection to prevent infection, including hospital-acquired infections (HAIs) and surgical site infections (SSIs). With the increase in demand in surgical and preoperative environments and the increasing awareness of infection prevention, the overall market will continue to expand.

This report presents a comprehensive overview of the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Antiseptic Wash Lotion & Solution
• Antiseptic Wipes & Gloves
• Antiseptic Caps
• Others

Segment by Application

• Operating Theatre
• Intensive Care Unit
• General Ward
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Chlorhexidine Gluconate Product for Patient Skin Antisepsis market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Operating Theatre, Intensive Care Unit, General Ward evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact